Jay Flatley

Type: Person
Name: Jay Flatley
First reported Apr 07 2014 - Updated Apr 08 2014 - 3 reports

Illumina to Announce First Quarter 2014 Financial Results on Tuesday, April 22, 2014

SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2014 following the close of market on Tuesday, April 22, 2014. On the same day, at 2:30 p.m. Pacific Time (5:30 p.m. Eastern ... [Published EON Science - Apr 07 2014]
First reported Mar 31 2014 - Updated Apr 01 2014 - 1 reports

Illumina: 9 Different Insiders Have Sold Shares This Month

SummaryNine insiders sold Illumina stock within one month. The stock was not purchased by any insiders in the month of intensive selling. Two of these nine insiders decreased their holdings by more than 10%.Illumina ( ILMN ) develops, manufactures, ... [Published Seeking Alpha - Mar 31 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

Illumina CEO sees bioinformatics as key to completing sequencing puzzle

Illumina CEO Jay FlatleyThe expansion of whole-genome sequencing into clinical care has intensified discussions about the limitations of the technology. Illumina ($ILMN) CEO Jay Flatley this week acknowledged that sequencing still has some weaknesses ... [Published Fierce Biotech IT - Mar 31 2014]
First reported Mar 30 2014 - Updated Mar 31 2014 - 2 reports

Digitizing Life: the genomics videos

Watch Craig Venter, Jay Flatley and Greg Lucier discuss the past and future of genomics.Related Biotechnology, Pharmaceutical and Healthcare NewsOriginal Article: NEXT ARTICLE More From BioPortfolio on "Digitizing Life: the genomics videos"Search Bi ... [Published BioPortfolio - Mar 31 2014]
First reported Mar 28 2014 - Updated Mar 28 2014 - 2 reports

Biotech leaders talk genomics

J. Craig Venter, Jay Flatley and Greg Lucier participate in a panel discussion in San Diego.Related Biotechnology, Pharmaceutical and Healthcare NewsOriginal Article: NEXT ARTICLE More From BioPortfolio on "Biotech leaders talk genomics"Search BioPo ... [Published BioPortfolio - Mar 28 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Illumina’s CEO on the Promise of the $1,000 Genome — And the Work That Remains

Courtesy: IlluminaIllumina seized the science world’s attention at the outset of the year by announcing it had achieved the $1,000 genome, crossing a long-sought threshold expected to accelerate advances in research and personalized medicine.The San Diego ... [Published Recode - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Dawkins, Venter to speak in San Diego

Some of the biggest figures in biology and physics will speak in La Jolla and Del Mar over the next week.MARCH 26 : DNA pioneers J. Craig Venter, Greg Lucier and Jay Flatley will appear at the Sanford Consortium in La Jolla to discuss, "Digitizing Life: ... [Published U-T San Diego - Mar 24 2014]
First reported Mar 11 2014 - Updated Mar 11 2014 - 1 reports

WuXi purchases Illumina HiSeq X Ten sequencing system

Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, and WuXi PharmaTech (Cayman) Inc., a leading pharmaceutical, biotechnology, and medical device ... [Published PharmaBiz - Mar 11 2014]
First reported Feb 21 2014 - Updated Feb 21 2014 - 1 reports

Mapping the human genome

Illumina CEO Jay Flatley on reducing the cost of mapping the human genome. ... [Published FOX Business - Video - Feb 21 2014]
First reported Feb 11 2014 - Updated Feb 11 2014 - 1 reports

Genome Management, Genome Factories and Other Audacious Goals Discussed at PMWC 2014

On January 27-28,  thought leaders from across multiple industries assembled at the Computer History Museum in Silicon Valley to discuss key themes in personalized medicine at the Personalized Medicine World Conference 2014 (PMWC) .  Having been in ... [Published mendelspod.com - Feb 11 2014]
First reported Jan 20 2014 - Updated Jan 20 2014 - 1 reports

J.P. Morgan: Pharma’s Agenda for 2014

Presenters at the 32 nd annual J.P. Morgan Healthcare Conference talked up value-based pricing, emerging market strategies, complex generics and new technology, from bedside devices and genetic sequencers to first-in-class mechanisms of action. Company ... [Published Pharmaceutical Executive - Jan 20 2014]
First reported Jan 15 2014 - Updated Jan 15 2014 - 2 reports

The $1,000 genome could actually be here

People want to know what their genes mean for their current and future health. And researchers want more people to reveal their genome because it helps them better understand the significance of DNA anomalies, helping to improve the analytics that make ... [Published GigaOM - Jan 15 2014]

Quotes

...and used sequencing technology that is now at least two years old, Flatley acknowledged that the software component of the workflow can improve. "what's hard is to determine whether there's a base inserted or deleted. that's a bioinformatics problem, not a sequencing problem. that's a software issue that we and others and the whole world is trying to work on" Flatley said
"We could have been running microarrays on every patient in clinical trials 10 years ago," Flatley said. "and when you really probe under the cover to figure out why that was, the reason was they were afraid to create data they couldn't explain to the fda. and i think that's been an underlying problem in the use in clinical trials. and the new fda, if you will, is beginning to realize that ngs really does create that level of uncertainty and they have to figure out how to live with it."

More Content

All (18) | News (10) | Reports (0) | Blogs (8) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Illumina to Announce First Quarter 2014 Financi... [Published EON Science - Apr 07 2014]
Illumina to Announce First Quarter 2014 Financi... [Published Business Wire Science: Science News - Apr 07 2014]
Illumina to Announce First Quarter 2014 Financi... [Published Business Wire Health News - Apr 07 2014]
Illumina: 9 Different Insiders Have Sold Shares... [Published Seeking Alpha - Mar 31 2014]
Illumina CEO sees bioinformatics as key to comp... [Published Fierce Biotech IT - Mar 31 2014]
Digitizing Life: the genomics videos [Published BioPortfolio - Mar 31 2014]
Digitizing Life: the genomics videos [Published U-T San Diego - Mar 30 2014]
Biotech leaders talk genomics [Published BioPortfolio - Mar 28 2014]
Biotech leaders talk genomics [Published U-T San Diego - Mar 28 2014]
Illumina’s CEO on the Promise of the $1,000 Gen... [Published Recode - Mar 25 2014]
Dawkins, Venter to speak in San Diego [Published U-T San Diego - Mar 24 2014]
WuXi purchases Illumina HiSeq X Ten sequencing ... [Published PharmaBiz - Mar 11 2014]
Mapping the human genome [Published FOX Business - Video - Feb 21 2014]
Genome Management, Genome Factories and Other A... [Published mendelspod.com - Feb 11 2014]
J.P. Morgan: Pharma’s Agenda for 2014 [Published Pharmaceutical Executive - Jan 20 2014]
This is real innovation: Illumina’s new machine... [Published Venturebeat - Jan 17 2014]
The $1,000 genome could actually be here [Published GigaOM - Jan 15 2014]
The $1,000 genome could actually be here [GigaOM] [Published GigaOM Network - Jan 15 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Illumina to Announce First Quarter 2014 Financi... [Published EON Science - Apr 07 2014]
SAN DIEGO--(EON: Enhanced Online News)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2014 following the close of market on Tuesday, April 22, 2014. On the same day, at 2:30 p.m. Pacific Time (5:30 p.m. Eastern ...
Illumina to Announce First Quarter 2014 Financi... [Published Business Wire Science: Science News - Apr 07 2014]
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2014 following the close of market on Tuesday, April 22, 2014. On the same day, at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) Jay ...
Illumina to Announce First Quarter 2014 Financi... [Published Business Wire Health News - Apr 07 2014]
SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2014 following the close of market on Tuesday, April 22, 2014. On the same day, at 2:30 p.m. Pacific Time (5:30 p.m. Eastern Time) Jay ...
Mapping the human genome [Published FOX Business - Video - Feb 21 2014]
Illumina CEO Jay Flatley on reducing the cost of mapping the human genome. ...
Genome Management, Genome Factories and Other A... [Published mendelspod.com - Feb 11 2014]
On January 27-28,  thought leaders from across multiple industries assembled at the Computer History Museum in Silicon Valley to discuss key themes in personalized medicine at the Personalized Medicine World Conference 2014 (PMWC) .  Having been in ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.